CSN Login
Members Online: 5

how these numbers are determined

PureSerenity
Posts: 3
Joined: Mar 2013

When my doc told me we were gonna do 30 treatments, he said that was his "ballpark" number. that being said, how do they determine these numbers???  I have 4 left, and i do not think i can emotionally or physically take 1 more day!!! so will these last 4 really make a difference??? I just dont think i can do this anymore!!! Any advice???

NYinTX's picture
NYinTX
Posts: 64
Joined: Feb 2013

Peer-Reviewed Original Research Articles

1.

Song S, Hong JC, McDonnell SE, Koong AC, Minsky BD, Chang DT, Liauw SL. Combined Modality Therapy for Rectal Cancer: The Relative Value of Posttreatment Versus Pretreatment CEA as a Prognostic Marker for Disease Recurrence. Ann Surg Oncol 19(8):2471-6, 2012. PMID: 22327251.

2.

Tonlaar N, Song S, Hong JC, Minsky BD, Chang DT, Polite BN, Liauw SL. Combined-modality Therapy for Rectal Cancer: Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race. Am J Clin Oncol. e-Pub 2012. PMID: 23211225.

3.

Guillem JG, Ruby JA, Leibold T, Akhurst TJ, Yeung HW, Gollub MJ, Ginsberg MS, Shia J, Suriawinata AA, Riedel ER, Mazumdar M, Saltz LB, Minsky BD, Nash GM, Paty PB, Temple LK, Weiser MR, Larson SM. Neither FDG-PET Nor CT Is Able to Distinguish Between a Pathological Complete Response and an Incomplete Response After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study. Ann Surg, 2012. PMID: 23187748.

4.

Ilson DH, Minsky BD, Ku GY, Rusch V, Rizk N, Shah M, Kelsen DP, Capanu M, Tang L, Campbell J, Bains M. Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer. Cancer 118(11):2820-7, 2012. PMID: 21990000.

5.

Goodman KA, Khalid N, Kachnic LA, Minsky BD, Crozier C, Owen JB, Devlin PM, Thomas CR. Quality Research in Radiation Oncology Analysis of Clinical Performance Measures in the Management of Gastric Cancer. Int J Radiat Oncol Biol Phys, 2012. PMID: 23040221.

6.

Golden DW, Novak CJ, Minsky BD, Liauw SL. Radiation dose >=54 Gy and CA 19--9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation. Radiat Oncol 7(1):156, 2012. PMID: 22974515.

7.

Leibold T, Akhurst TJ, Chessin DB, Yeung HW, Macapinlac H, Shia J, Minsky BD, Saltz LB, Riedel E, Mazumdar M, Paty PB, Weiser MR, Wong WD, Larson SM, Guillem JG. Evaluation of F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis. Ann Surg Oncol 18(10):2783-9, 2011. PMID: 21476107.

8.

Kachnic LA, Winter K, Wasserman T, Kelsen D, Ginsberg R, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Willett CG, Minsky BD. Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer. Gastrointest Cancer Res 4(2):45-52, 2011. PMID: 21673875.

9.

Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, Gerard JP, Rdel C, Sainato A, Sauer R, Minsky BD, Collette L, Lambin P. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 29(23):3163-72, 2011. PMID: 21747092.

10.

Edelson DP, Retzer E, Weidman EK, Woodruff J, Davis AM, Minsky BD, Meadow W, Hoek TL, Meltzer DO. Patient acuity rating: quantifying clinical judgment regarding inpatient stability. J Hosp Med 6(8):475-9, 2011. PMID: 21853529.

11.

Marsland T, Arena F, Yeilding A, Glod M, Ellis L, Yu J, Henderson C, Wagman L, Piver S, Minsky B, Rosen S, Poplack D, Potters L, Crawford D, Hoskins W. Perspective on.the new PSA screening recommendations. Oncology (Williston Park) 25(12):1183, 1187-8, 1190, 2011. PMID: 22229211.

12.

Shia J, McManus M, Guillem JG, Leibold T, Zhou Q, Tang LH, Riedel ER, Weiser MR, Paty PB, Temple LK, Nash G, Kolosov K, Minsky BD, Wong WD, Klimstra DS. Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol 35(1):127-34, 2011. PMID: 21164296.

13.

Wright JL, Gollub MJ, Weiser MR, Saltz LB, Wong WD, Paty PB, Temple LK, Guillem JG, Minsky BD, Goodman KA. Surgery and high-dose-rate intraoperative radiation therapy for recurrent squamous-cell carcinoma of the anal canal. Dis Colon Rectum 54(9):1090-7, 2011. PMID: 21825888.

14.

Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R, Grothey A, Haller D, Haustermans K, Kerr D, Nordlinger B, Marshall J, Minsky BD, Kang YK, Labianca R, Lordick F, Ohtsu A, Pavlidis N, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Van de Velde C, Zalcberg J. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol 22 Suppl 5:v1-9, 2011. PMID: 21633049.

15.

Cunnigham D, Atkin W, Lenz HJ, Lynch HT, Minsky BD, Nordlinger B, Starling N. Colorectal Cancer. Lancet 375:1030-1047, 2010.

16.

Van Cutsem E, Dicato M, Arber N, Berlin J, Cervantes A, Ciardiello F, De Gramont A, Diaz-Rubio E, Ducreux M, Geva R, Glimelius B, Glynne Jones R, Grothey A, Gruenberger T, Haller D, Haustermans K, Labianca R, Lenz HJ, Minsky B, Nordlinger B, Ohtsu A, Pavlidis N, Rougier P, Schmiegel W, Van de Velde C, Schmoll HJ, Sobrero A, Tabernero J. Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009. Ann Oncol 21 Suppl 6:vi1-10, 2010. PMID: 20534623.

17.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK,Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN. Protocol for the examination of specimens from patients with carcinoma of the distal extrahepatic bile ducts. Arch Pathol Lab Med 134:e8-e13, 2010.

18.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK,Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN. Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts. Arch Pathol Lab Med 134:e14-e18, 2010.

19.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK,Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN. Protocol for the examination of specimens from patients with carcinoma of the perihilar bile ducts. Arch Pathol Lab Med 134:e19-e24, 2010.

20.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK,Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the appendix. Arch Pathol Lab Med 134:171-175, 2010.

21.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK,Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum. Arch Pathol Lab Med 134:176-180, 2010.

22.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK,Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla. Arch Pathol Lab med 134:181-186, 2010.

23.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK,Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the stomach. Arch Pathol Lab Med 134:187-191, 2010.

24.

Wright JL, Patil SM, Temple LK, Minsky BD, Saltz LB, Goodman KA. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. Int J Radiat Oncol Biol Phys 78(4):1064-72, 2010. PMID: 20350793.

25.

Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, Haustermans K, Maingon P, Overgaard J, Pahlman L, Quirke P, Schmoll HJ, Sebag-Montefiore D, Taylor I, Van Cutsem E, Van de Velde C, Cellini N, Latini P, Scientific Committee. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 92(2):148-63, 2009. PMID: 19595467.

26.

Sarkaria IS, Rizk NP, Bains MS, Tang LH, Ilson DH, Minsky B, Rusch VW. Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer. Ann Surg 249(5):764-7, 2009. PMID: 19387328.

27.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Compton CC. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch Pathol Lab Med 133:1539-1551, 2009.

28.

Schwartz GK, Winter K, Minsky BD, Crane C, Thomson PJ, Anne P, Gross H, Willett C, Kelsen D. Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114). J Clin Oncol 27(12):1956-62, 2009. PMID: 19273696.

29.

Weiser MR, Quah HM, Shia J, Guillem JG, Paty PB, Temple LK, Goodman KA, Minsky BD, Wong WD. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg 249(2):236-42, 2009. PMID: 19212176.

30.

Valentini V, Cellini F, Minsky BD, Mattiucci GC, Balducci M, D'Agostino G, D'Angelo E, Dinapoli N, Nicolotti N, Valentini C, La Torre G. Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiother Oncol 92(2):176-83, 2009. PMID: 19586672.

31.

Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, OReilly. A phase I study of erlotinib in combination with gemcitibine and radiation in locally advanced pancreatic adenocarcinoma. Ann Oncol 19:86-91, 2008.

32.

Guillem JG, Daz-Gonzlez JA, Minsky BD, Valentini V, Jeong SY, Rodriguez-Bigas MA, Coco C, Leon R, Hernandez-Lizoain JL, Aristu JJ, Riedel ER, Nitti D, Wong WD, Pucciarelli S. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 26(3):368-73, 2008. PMID: 18202411.

33.

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 113(1):57-64, 2008. PMID: 18442099.

34.

Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD, Liao Z, Bradley J, Fromm M, Hornback D, Willett CG. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol 26(28):4551-6, 2008. PMID: 18574157.

35.

Nahas CS, Akhurst T, Yeung H, Leibold T, Riedel E, Markowitz AJ, Minsky BD, Paty PB, Weiser MR, Temple LK, Wong WD, Larson SM, Guillem JG. Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation. Ann Surg Oncol 15(3):704-11, 2008. PMID: 17882490.

36.

Lin AY, Wong WD, Shia J, Minsky BD, Temple LK, Guillem JG, Paty PB, Weiser MR. Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy. Int J Colorectal Dis 23(3):243-9, 2008. PMID: 18046561.

37.

Leibold T, Shia J, Ruo L, Minsky BD, Akhurst T, Gollub MJ, Ginsberg MS, Larson S, Riedel E, Wong WD, Guillem JG. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol 26(13):2106-11, 2008. PMID: 18362367.

38.

Valentini V, Coco C, Minsky BD, Gambacorta MA, Cosimelli M, Bellavita R, Morganti AG, La Torre G, Trodella L, Genovesi D, Portaluri M, Maurizi-Enrici R, Barbera F, Maranzano E, Lupattelli M. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy. Int J Radiat Oncol Biol Phys 70(2):403-12, 2008. PMID: 17919844.

39.

Ku GY, Minsky BD, Rusch VW, Bains M, Kelsen DP, Ilson DH. Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol 19(3):533-7, 2008. PMID: 17947223.

40.

Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 51(2):147-53, 2008. PMID: 18180997.

41.

Van Cutsem E, Dicato M, Haustermans K, Arber N, Bosset JF, Cunningham D, De Gramont A, Diaz-Rubio E, Ducreux M, Goldberg R, Glynne-Jones R, Haller D, Kang YK, Kerr D, Labianca R, Minsky BD, Moore M, Nordlinger B, Rougier P, Scheithauer W, Schmoll HJ, Sobrero A, Tabernero J, Tempero M, Van de Velde C, Zalcberg J. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. Ann Oncol 19 Suppl 6:vi1-8, 2008. PMID: 18539618.

42.

Guillem JG, Chessin DB, Shia J, Suriawinata A, Riedel E, Moore HG, Minsky BD, Wong WD. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg 245(1):88-93, 2007. PMID: 17197970.

43.

Rizk NP, Venkatraman E, Bains MS, Park B, Flores R, Tang L, Ilson DH, Minsky BD, Rusch VW, American Joint Committee on Cancer. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 25(5):507-12, 2007. PMID: 17290058.

44.

Neuman HB, Schrag D, Cabral C, Weiser MR, Paty PB, Guillem JG, Minsky BD, Wong WD, Temple LK. Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument? Ann Surg Oncol 14(5):1727-34, 2007. PMID: 17265117.

45.

Anderson SE, Minsky BD, Bains M, Hummer A, Kelsen D, Ilson DH. Combined modality chemoradiation in elderly oesophageal cancer patients. Br J Cancer 96(12):1823-7, 2007. PMID: 17533399.

46.

Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, Ajani JA, Kocha W, Minsky BD, Roth JA, Willett CG, Radiation Therapy Oncology Group, USA Intergroup. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25(24):3719-25, 2007. PMID: 17704421.

47.

Rizk NP, Seshan VE, Bains MS, Ilson DH, Minsky BD, Tang L, Rusch VW. Prognostic factors after combined modality treatment of squamous cell carcinoma of the esophagus. J Thorac Oncol 2(12):1117-23, 2007. PMID: 18090585.

48.

Nahas CS, Shia J, Joseph R, Schrag D, Minsky BD, Weiser MR, Guillem JG, Paty PB, Klimstra DS, Tang LH, Wong WD, Temple LK. Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum 50(9):1393-400, 2007. PMID: 17661147.

49.

Verslype E, Van Cutsem E, Dicato M, Cascinu S, Cunningham D, Diaz-Rubio E, Glimelius B, Haller D, Haustermans K, Heinemann V, Hoff P, Johnston PG, Kerr D, Labianca R, Louvet C, Minsky B, Moore M, Nordlinger B, Pedrazzoli S, Roth A, Rothenberg M, Rougier P, Schmoll HJ, Tabernero H, Tempero M, van de Velde C, Van Laethem JL, Zalcberg J. The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncolo 18:vii1-vii10, 2007.

50.

Stipa F, Chessin DB, Shia J, Paty PB, Weiser M, Temple LK, Minsky BD, Wong WD, Guillem JG. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 13(8):1047-53, 2006. PMID: 16865595.

51.

Ajani J, Bekaii-Saab T, D'Amico TA, Fuchs C, Gibson MK, Goldberg M, Hayman JA, Ilson DH, Javle M, Kelley S, Kurtz RC, Locker GY, Meropol NJ, Minsky BD, Orringer MB, Osarogiagbon RU, Posey JA, Roth J, Sasson AR, Swisher SG, Wood DE, Yen Y. Esophageal Cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 4(4):328-47, 2006. PMID: 16569387.

52.

Ajani J, Bekaii-Saab T, D'Amico TA, Fuchs C, Gibson MK, Goldberg M, Hayman JA, Ilson DH, Javle M, Kelley S, Kurtz RC, Locker GY, Meropol NJ, Minsky BD, Orringer MB, Osarogiagbon RU, Posey JA, Roth J, Sasson AR, Swisher SG, Wood DE, Yen Y. Gastric Cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 4(4):350-66, 2006. PMID: 16569388.

53.

Nissan A, Stojadinovic A, Shia J, Hoos A, Guillem JG, Klimstra D, Cohen AM, Minsky BD, Paty PB, Wong WD. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 24(25):4078-84, 2006. PMID: 16943525.

54.

Ballas LK, Elkin EB, Schrag D,Minsky BD, Bach PB. Radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys 66(4):1204-11, 2006. PMID: 17145535.

55.

Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE, Guillem JG, Weiser MR, Cohen AM, Minsky BD, Wong WD, Temple LK. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 49(8):1099-107, 2006. PMID: 16779712.

56.

Rengan R, Paty PB, Wong WD, Guillem JG, Weiser M, Temple L, Saltz L, Minsky BD. Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders. Clin Colorectal Cancer 5(6):413-21, 2006. PMID: 16635280.

57.

Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 294(21):2703-11, 2005. PMID: 16333005.

58.

Katz MS, Minsky BD, Saltz LB, Riedel E, Chessin DB, Guillem JG. Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 62(5):1363-70, 2005. PMID: 16029794.

59.

Guillem JG, Chessin DB, Shia J, Moore HG, Mazumdar M, Bernard B, Paty PB, Saltz L, Minsky BD, Weiser MR, Temple LK, Cohen AM, Wong WD. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol 23(15):3475-9, 2005. PMID: 15908656.

60.

Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ, American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 23(33):8512-9, 2005. PMID: 16260687.

61.

Chessin DB, Enker W, Cohen AM, Paty PB, Weiser MR, Saltz L, Minsky BD, Wong WD, Guillem JG. Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. J Am Coll Surg 200(6):876-82, 2005. PMID: 15922198.

62.

Rengan R, Paty P, Wong WD, Guillem J, Weiser M, Temple L, Saltz L, Minsky BD. Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection? J Clin Oncol 23(22):4905-12, 2005. PMID: 16051945.

63.

Guillem JG, Chessin DB, Cohen AM, Shia J, Mazumdar M, Enker W, Paty PB, Weiser MR, Klimstra D, Saltz L, Minsky BD, Wong WD. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241(5):829-36, 2005. PMID: 15849519.

64.

Suntharalingam M, Moughan J, Coia LR, Krasna MJ, Kachnic L, Haller DG, Willet CG, John MJ, Minsky BD, Owen JB. Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus. J Clin Oncol 23(10):2325-31, 2005. PMID: 15800323.

65.

Chessin DB, Hartley J, Cohen AM, Mazumdar M, Cordeiro P, Disa J, Mehrara B, Minsky BD, Paty P, Weiser M, Wong WD, Guillem JG. Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol 12(2):104-10, 2005. PMID: 15827789.

66.

Weiser MR, Landmann RG, Wong WD, Shia J, Guillem JG, Temple LK, Minsky BD, Cohen AM, Paty PB. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 48(6):1169-75, 2005. PMID: 15793645.

67.

Bentrem DJ, Okabe S, Wong WD, Guillem JG, Weiser MR, Temple LK, Ben-Porat LS, Minsky BD, Cohen AM, Paty PB. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg 242(4):472-7, 2005. PMID: 16192807.

68.

Temple LK, Bacik J, Savatta SG, Gottesman L, Paty PB, Weiser MR, Guillem JG, Minsky BD, Kalman M, Thaler HT, Schrag D, Wong WD. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum 48(7):1353-65, 2005. PMID: 15868235.

69.

Valentini V, Glimelius B, Minsky BD, Van Cutsem E, Bartelink H, Beets-Tan RG, Gerard JP, Kosmidis P, Pahlman L, Picciocchi A, Quirke P, Tepper J, Tonato M, Van de Velde CJ, Cellini N, Latini P. The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother Oncol 76(3):241-50, 2005. PMID: 16165238.

70.

Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Miccich F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62(3):752-60, 2005. PMID: 15936556.

71.

Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M, Paty PB, Wong WD, Guillem JG. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 47(10):1599-606, 2004. PMID: 15540287.

72.

Moore HG, Shia J, Klimstra DS, Ruo L, Mazumdar M, Schwartz GK, Minsky BD, Saltz L, Guillem JG. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome. Ann Surg Oncol 11(11):955-61, 2004. PMID: 15525823.

73.

Bernick PB, Klimstra DS, Shia J, Minsky BD, Saltz L, Shi W, Thaler H, Guillem J, Paty P, Cohen AM, Wong WD. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum 47:163-169, 2004.

74.

Akbari RP, Paty PB, Guillem JG, Weiser MR, Temple LK, Minsky BD, Saltz L, Wong WD. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 47(7):1136-44, 2004. PMID: 15164245.

75.

Shia J, Guillem JG, Moore HG, Tickoo SK, Qin J, Ruo L, Suriawinata A, Paty PB, Minsky BD, Weiser MR, Temple LK, Wong WD, Klimstra DS. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 28(2):215-23, 2004. PMID: 15043311.

76.

Brenner B, Ilson DH, Minsky BD, Bains MS, Tong W, Gonen M, Kelsen DP. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy. J Clin Oncol 22(1):45-52, 2004. PMID: 14701767.

77.

Moore HG, Gittleman AE, Minsky BD, Wong D, Paty PB, Weiser M, Temple L, Saltz L, Shia J, Guillem JG. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 47(3):279-86, 2004. PMID: 14991488.

78.

Thomas CR, Berkey BA, Minsky BD, Gaspar LE, Herskovic A, Rich TA, Gunderson LL. Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys 58(5):1405-10, 2004. PMID: 15050316.

79.

Stipa F, Zernecke A, Moore HG, Minsky BD, Wong WD, Weiser M, Paty PB, Shia J, Guillem JG. Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? Ann Surg Oncol 11(2):187-91, 2004. PMID: 14761922.

80.

Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, Minsky BD, Saltz L, Wong WD, Larson S. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg 199(1):1-7, 2004. PMID: 15217621.

81.

Idrees K, Guillem JG, Wong WD, Weiser MR, Temple L, Alekitar K, Minsky BD, Paty PB. Surgical resection and high dose rate intraoperative radiation therapy for locally recurrent rectal cancer; a brief review 51:11-18, 2004.

82.

Moore HG, Akhurst T, Larson SM, Minsky BD, Mazumdar M, Guillem JG. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 197(1):22-8, 2003. PMID: 12831920.

83.

Moore HG, Riedel E, Minsky BD, Saltz L, Paty P, Wong D, Cohen AM, Guillem JG. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 10(1):80-5, 2003. PMID: 12513965.

84.

Anderson SE, Minsky BD, Bains M, Kelsen DP, Ilson DH. Combined modality therapy in esophageal cancer: the Memorial experience. Semin Surg Oncol 21(4):228-32, 2003. PMID: 14648780.

85.

Nathanson DR, Espat NJ, Nash GM, D'Alessio M, Thaler H, Minsky BD, Enker W, Wong D, Guillem J, Cohen A, Paty PB. Evaluation of preoperative and postoperative radiotherapy on long-term functional results of straight coloanal anastomosis. Dis Colon Rectum 46(7):888-94, 2003. PMID: 12847361.

86.

Ilson DH, Bains M, Kelsen DP, O'Reilly E, Karpeh M, Coit D, Rusch V, Gonen M, Wilson K, Minsky BD. Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. J Clin Oncol 21(15):2926-32, 2003. PMID: 12885811.

87.

Beal KP, Wong D, Guillem JG, Paty PB, Saltz LL, Wagman R, Minsky BD. Primary adenocarcinoma of the anus treated with combined modality therapy. Dis Colon Rectum 46(10):1320-4, 2003. PMID: 14530668.

88.

Picon AI, Moore HG, Sternberg SS, Minsky BD, Paty PB, Blumberg D, Quan SH, Wong WD, Cohen AM, Guillem JG. Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis 18(6):487-92, 2003. PMID: 12783251.

89.

Wagman R, Yorke E, Ford E, Giraud P, Mageras G, Minsky B, Rosenzweig K. Respiratory gating for liver tumors: use in dose escalation. Int J Rad Oncol Biol Phys 55:659-668, 2003.

90.

Ruo L, Paty PB, Minsky BD, Wong WD, Cohen AM, Guillem JG. Results after rectal cancer resection with in-continuity partial vaginectomy and total mesorectal excision. Ann Surg Oncol 10(6):664-8, 2003. PMID: 12839851.

91.

Temple LK, Wong WD, Minsky B. The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Semin Radiat Oncol 13(4):469-77, 2003. PMID: 14586835.

92.

Suntharalingam M, Moughan J, Coia LR, Krasna MJ, Kachnic L, Haller DG, Willett CG, John MJ, Minsky BD, Owen JB, 1996-1999 Patterns of Care Study. The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care Study. Int J Radiat Oncol Biol Phys 56(4):981-7, 2003. PMID: 12829133.

93.

Downey RJ, Akhurst T, Ilson D, Ginsberg R, Bains MS, Gonen M, Koong H, Gollub M, Minsky BD, Zakowski M, Turnbull A, Larson SM, Rusch V. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 21(3):428-32, 2003. PMID: 12560430.

94.

Bains MS, Stojadinovic A, Minsky B, Rusch V, Turnbull A, Korst R, Ginsberg R, Kelsen DP, Ilson DH. A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. J Thorac Cardiovasc Surg 124(2):270-7, 2002. PMID: 12167786.

95.

Van Cutsem E, Dicato M, Wils J, Cunningham D, Diaz-Rubio E, Glimelius B, Haller D, Johnston P, Kerr D, Koehne CH, Labianca R, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ. Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer 38(11):1429-36, 2002. PMID: 12110487.

96.

Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 194(2):131-5, 2002. PMID: 11848629.

97.

Smalley SR, Gunderson L, Tepper J, Martenson JA, Minsky B, Willett C, Rich T. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys 52(2):283-93, 2002. PMID: 11872272.

98.

Shia J, Tickoo SK, Guillem JG, Qin J, Nissan A, Hoos A, Stojadinovic A, Ruo L, Wong WD, Paty PB, Weiser MR, Minsky BD, Klimstra DS. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol 26(7):863-72, 2002. PMID: 12131153.

99.

Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20(5):1167-74, 2002. PMID: 11870157.

100.

Hanna NN, Guillem J, Dosoretz A, Steckelman E, Minsky BD, Cohen AM. Intraoperative parasympathetic nerve stimulation with tumescence monitoring during total mesorectal excision for rectal cancer. J Am Coll Surg 195(4):506-12, 2002. PMID: 12375756.

101.

Ruo L, Tickoo S, Klimstra DS, Minsky BD, Saltz L, Mazumdar M, Paty PB, Wong WD, Larson SM, Cohen AM, Guillem JG. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 236(1):75-81, 2002. PMID: 12131088.

102.

Paty PB, Nash GM, Baron P, Zakowski M, Minsky BD, Blumberg D, Nathanson DR, Guillem JG, Enker WE, Cohen AM, Wong WD. Long-term results of local excision for rectal cancer. Ann Surg 236(4):522-29, 2002. PMID: 12368681.

103.

Shoup M, Guillem JG, Alektiar KM, Liau K, Paty PB, Cohen AM, Wong WD, Minsky BD. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 45(5):585-92, 2002. PMID: 12004205.

104.

Ruo L, Guillem JG, Minsky BD, Quan SH, Paty PB, Cohen AM. Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers. Int J Colorectal Dis 17(1):54-8, 2002. PMID: 12018456.

105.

Nash GM, Saltz LB, Kemeny NE, Minsky B, Sharma S, Schwartz GK, Ilson DH, O'Reilly E, Kelsen DP, Nathanson DR, Weiser M, Guillem JG, Wong WD, Cohen AM, Paty PB. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 9(10):954-60, 2002. PMID: 12464586.

106.

Nissan A, Guillem JG, Paty PB, Douglas Wong W, Minsky B, Saltz L, Cohen AM. Abdominoperineal resection for rectal cancer at a specialty center. Dis Colon Rectum 44(1):27-35, 2001. PMID: 11805560.

107.

Minsky BD. Adjuvant radiation therapy for rectal cancer: is there finally an answer? Lancet 358(9290):1285-6, 2001. PMID: 11684204.

108.

Grann A, Feng C, Wong D, Saltz L, Paty PP, Guillem JG, Cohen AM, Minsky BD. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 49(4):987-95, 2001. PMID: 11240239.

109.

Willett C, Ajani J, Kelsen D, Sigurdson E, Abrams R, Berkey B, Benetz M, Crane C, Gaspar L, Goodyear MD, Gunderson L, Haddock M, Hoffmann J, Janjan N, John M, Kachnic L, Krieg R, Landry J, Meropol N, Minsky B, Mitchell E, Mohiuddin M, Moulder J, Myerson R, Noyes D, Pajak TF, Raben D, Regine W, Rich T, Robertson JM, Russell A, Skibber J, Kim P, Radiation Therapy Oncology Group. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee. Int J Radiat Oncol Biol Phys 51(3 Suppl 2):19-27, 2001. PMID: 11641011.

110.

Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. J Clin Oncol 19(17):3712-8, 2001. PMID: 11533092.

111.

Benson AB, Desch CE, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Petrelli NJ, Pfister DG, Smith TJ, Somerfield MR, American Society of Clinical Oncology. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 18(20):3586-8, 2000. PMID: 11032600.

112.

John MJ, Merrick GS, Coia LR, Minsky BD, Bader JL, Janjan NA, Raben D, Rich TA, Rosenthal SA, Tepper JE, Ota D, Saltz L, Leibel S. Anal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1501-11, 2000. PMID: 11037563.

113.

Shibata D, Guillem JG, Lanouette N, Paty P, Minsky B, Harrison L, Wong WD, Cohen A. Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation. Dis Colon Rectum 43(6):752-8, 2000. PMID: 10859073.

114.

Alektiar KM, Zelefsky MJ, Paty PB, Guillem J, Saltz LB, Cohen AM, Minsky BD. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 48(1):219-26, 2000. PMID: 10924992.

115.

Tepper JE, Bader JL, Janjan NA, Minsky BD, Coia LR, John MJ, Merrick GS, Raben D, Rich TA, Rosenthal SA, Ota D, Saltz L, Leibel S. Locally unresectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1481-90, 2000. PMID: 11037561.

116.

Rich TA, Ota D, Rosenthal SA, Minsky BD, Bader JL, Coia LR, Janjan NA, John MJ, Merrick GS, Raben D, Tepper JE, Saltz L, Leibel S. Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1473-80, 2000. PMID: 11037560.

117.

Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J, Pisansky TM, Willett CG, Hoffman JP, Owen JB, Hanks GE. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol 18(3):455-62, 2000. PMID: 10653860.

118.

Rosenthal DI, Haller DG, Saltz L, Semple D, Minsky BD. Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin. Oncology (Williston Park) 14(10 Suppl 9):59-62, 2000. PMID: 11098496.

119.

Guillem JG, Puig-La Calle J, Akhurst T,Tickoo S, Ruo L, Minsky BD, Gollub MJ, Klimstra DS, Mazumdar M, Paty PB , Macapinlac H, Yeung H, Saltz L, Finn RD, Erdi Y, Humm J, Cohen AM, Larson S. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 43(1):18-24, 2000. PMID: 10813118.

120.

Saltz L, Raben D, Minsky BD, Bader JL, Coia LR, Janjan NA, John MJ, Merrick GS, Rich TA, Rosenthal SA, Tepper JE, Ota D, Leibel S. Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1491-9, 2000. PMID: 11037562.

121.

Koea JB, Guillem JG, Conlon KC, Minsky B, Saltz L, Cohen A. Role of laparoscopy in the initial multimodality management of patients with near-obstructing rectal cancer. J Gastrointest Surg 4(1):105-8, 2000. PMID: 10631370.

122.

Hu K, Minsky BD, Cohen AM, Kelsen DP, Guillem JG, Paty PP, Quan SH. 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Oncol 70(2):71-7, 1999. PMID: 10084647.

123.

Blumberg D, Paty PB, Guillem JG, Picon AI, Minsky BD, Wong WD, Cohen AM. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 42(7):881-5, 1999. PMID: 10411434.

124.

Wagman R, Minsky BD, Cohen AM, Saltz L, Paty PB, Guillem JG. Conservative management of rectal cancer with local excision and postoperative adjuvant therapy. Int J Radiat Oncol Biol Phys 44(4):841-6, 1999. PMID: 10386641.

125.

Merchant TE, Minsky BD, Lauwers GY, Diamantis PM, Haida T, Glonek T. Esophageal cancer phospholipids correlated with histopathologic findings: a 31P NMR study. NMR Biomed 12(4):184-8, 1999. PMID: 10421909.

126.

Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg RJ, Pajak T, Salter M, Benson AB. Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43(3):517-23, 1999. PMID: 10078631.

127.

Desch CE, Benson AB, Smith TJ, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Petrelli NJ, Pfister DG, Somerfield MR. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol 17(4):1312, 1999. PMID: 10561194.

128.

Enker WE, Merchant N, Cohen AM, Lanouette NM, Swallow C, Guillem J, Paty P, Minsky B, Weyrauch K, Quan SH. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg 230(4):544-52, 1999. PMID: 10522724.

129.

Grann A, Paty PB, Guillem JG, Cohen AM, Minsky BD. Sphincter preservation of leiomyosarcoma of the rectum and anus with local excision and brachytherapy. Dis Colon Rectum 42(10):1296-9, 1999. PMID: 10528767.

130.

Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 6(2):171-7, 1999. PMID: 10082043.

131.

Merchant NB, Guillem JG, Paty PB, Enker WE, Minsky BD, Quan SH, Wong D, Cohen AM. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 3(6):642-7, 1999. PMID: 10554372.

132.

Coia LR, Minsky BD, John MJ, Haller DG, Landry J, Pisansky TM, Willett CG, Hoffman JP, Berkey BA, Owen JB, Hanks GE. The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care Study. Cancer 85(12):2499-505, 1999. PMID: 10375094.

133.

Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339(27):1979-84, 1998. PMID: 9869669.

134.

Harrison LB, Minsky BD, Enker WE, Mychalczak B, Guillem J, Paty PB, Anderson L, White C, Cohen AM. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys 42(2):325-30, 1998. PMID: 9788411.

135.

Minsky BD. Multidisciplinary case teams: an approach to the future management of advanced colorectal cancer. Br J Cancer 77 Suppl 2:1-4, 1998. PMID: 9579848.

136.

Coia LR, Minsky BD, John MJ, Haller D, Landry J, Pisansky TM, Willet CG, Mahon I, Owen J, Hanks GE. Patterns of care study decision tree and management guidelines for esophageal cancer. American College of Radiology. Radiat Med 16(4):321-7, 1998. PMID: 9814432.

137.

Minsky BD, Coia L, Haller DG, Hoffman J, John M, Landry J, Pisansky TM, Willett C, Mahon I, Owen J, Berkey B, Katz A, Hanks G. Radiation therapy for rectosigmoid and rectal cancer: results of the 1992-1994 Patterns of Care process survey. J Clin Oncol 16(7):2542-7, 1998. PMID: 9667276.

138.

Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys 42(1):51-7, 1998. PMID: 9747819.

139.

Blumberg D, Paty PB, Picon AI, Guillem JG, Klimstra DS, Minsky BD, Quan SH, Cohen AM. Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg 186(5):574-9, 1998. PMID: 9583699.

140.

Minsky BD, Coia L, Haller D, Hoffman J, John M, Landry J, Pisansky TM, Willett C, Mahon I, Owen J, Hanks G. Treatment systems guidelines for primary rectal cancer from the 1996 Patterns of Care Study. Int J Radiat Oncol Biol Phys 41(1):21-7, 1998. PMID: 9588913.

141.

PCS Consensus Committee. 1996 decision trees and management guidelines. Sem Radiat Oncol 7:163-181, 1997.

142.

Grann A, Minsky BD, Cohen AM, Saltz L, Guillem JG, Paty PB, Kelsen DP, Kemeny N, Ilson D, Bass-Loeb J. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 40(5):515-22, 1997. PMID: 9152176.

143.

Minsky BD, Cohen AM, Enker WE, Saltz L, Guillem JG, Paty PB, Kelsen DP, Kemeny N, Ilson D, Bass J, Conti J. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 37(2):289-95, 1997. PMID: 9069299.

144.

Minsky BD, Conti J, Cohen AM, Kelsen DP, Saltz L, Guillem J, Paty P, Bass J, Bertino JR. Acute toxicity of neoadjuvant bolus 5-FU/methotrexate followed by oral leucovorin and continuous infusion 5-FU plus pre-operative radiation therapy for rectal cancer. Rad Oncol Invest 4:90-97, 1996.

145.

Moni J, Armstrong JG, Minsky BD, Bains MS, Harrison LB. High dose rate intraluminal brachytherapy for carcinoma of the esophagus. Dis Esoph 9:123-127, 1996.

146.

Havenga K, Enker WE, McDermott K, Cohen AM, Minsky BD, Guillem J. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 182(6):495-502, 1996. PMID: 8646349.

147.

Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg R, Benson A. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122. J Clin Oncol 14(1):149-55, 1996. PMID: 8558190.

148.

Merchant TE, Diamantis PM, Lauwers G, Haida T, Kasimos JN, Guillem J, Glonek T, Minsky BD. Characterization of malignant colon tumors with 31P nuclear magnetic resonance phospholipid and phosphatic metabolite profiles. Cancer 76(10):1715-23, 1995. PMID: 8625039.

149.

Minsky BD, Enker WE, Cohen AM, Lauwers G. Clinicopathologic features in rectal cancer treated by local excision and postoperative radiation therapy. Radiat Med 13(5):235-41, 1995. PMID: 8848558.

150.

Minsky BD, Cohen AM, Enker WE, Kelsen DP, Kemeny N, Frankel J. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer. Cancer Invest 13(1):1-7, 1995. PMID: 7834464.

151.

Merchant TE, Schwartz LH, Ballon D, Koutcher JA, Scher HI, Minsky BD. Intracavitary birdcage resonator: applications to the human prostate. J Magn Reson Imaging 5(3):365-8, 1995. PMID: 7633116.

152.

Minsky BD, Conti JA, Huang Y, Knopf K. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 13(6):1409-16, 1995. PMID: 7751886.

153.

Minsky BD, Cohen AM, Enker WE, Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 31(3):553-9, 1995. PMID: 7852119.

154.

Jessup JM, Lavin PT, Andrews CW, Loda M, Mercurio A, Minsky BD, Mies C, Cukor B, Bleday R, Steele G. Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma. Dis Colon Rectum 38(12):1257-64, 1995. PMID: 7497836.

155.

Merchant TE, van der Ven LT, Minsky BD, Diamantis PM, Delapaz R, Galicich J, Glonek T. 31P NMR phospholipid characterization of intracranial tumors. Brain Res 649(1-2):1-6, 1994. PMID: 7953620.

156.

Conti J, Kemeny N, Minsky BD. Combined modality therapy of rectal cancer: past results and future directions. J Infusional Chemo 4:124-130, 1994.

157.

Minsky BD, Enker WE, Cohen AM, Lauwers G. Local excision and postoperative radiation therapy for rectal cancer. Am J Clin Oncol 17(5):411-6, 1994. PMID: 8092113.

158.

Paty PB, Enker WE, Cohen AM, Minsky BD, Friedlander-Klar H. Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg 167(1):90-4, 1994. PMID: 8311145.

159.

Seijo L, Merchant TE, van der Ven LT, Minsky BD, Glonek T. Meningioma phospholipid profiles measured by 31P nuclear magnetic resonance spectroscopy. Lipids 29(5):359-64, 1994. PMID: 8015367.

160.

Merchant TE, Ballon D, Koutcher JA, Miodownik S, Schwartz L, Minsky BD. A birdcage resonator for intracavitary MR imaging. Magn Reson Imaging 11(8):1119-27, 1993. PMID: 8271898.

161.

Minsky BD. Clinical experience with local excision and postoperative radiation therapy for rectal cancer. Dis Colon Rectum 36(4):405-9, 1993. PMID: 8458271.

162.

Merchant TE, de Graaf PW, Minsky BD, Obertop H, Glonek T. Esophageal cancer phospholipid characterization by 31P NMR. NMR Biomed 6(3):187-93, 1993. PMID: 8347452.

163.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Schwartz G, Saltz L, Dougherty J, Frankel J, Wiseberg J. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Int J Radiat Oncol Biol Phys 25(5):821-7, 1993. PMID: 8478232.

164.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Saltz L, Frankel J. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer 71(11):3486-92, 1993. PMID: 8490898.

165.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 10(8):1218-24, 1992. PMID: 1634912.

166.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 10(1):79-84, 1992. PMID: 1727928.

167.

Minsky BD, Cohen AM, Enker WE, Kelsen DP, Kemeny N, Riechman B, Saltz L, Sigurdson ER, Frankel J. Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer. Int J Radiat Oncol Biol Phys 22(1):139-45, 1992. PMID: 1727111.

168.

Minsky BD, Cohen AM, Enker WE, Sigurdson E. Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. Int J Radiat Oncol Biol Phys 23(2):387-92, 1992. PMID: 1587760.

169.

Enker WE, Paty PB, Minsky BD, Cohen AM. Restorative or preservative operations in the treatment of rectal cancer. Surg Oncol Clin N Am 1:57-69, 1992.

170.

Minsky B, Botet J, Gerdes H, Lightdale C. Ultrasound directed extrahepatic bile duct intraluminal brachytherapy. Int J Radiat Oncol Biol Phys 23(1):165-7, 1992. PMID: 1315312.

171.

Brodsky JT, Richard GK, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 69(2):322-6, 1992. PMID: 1728363.

172.

Minsky BD, Cohen AM, Enker WE, Kelsen D, Kemeny N, Sigurdson E. Adjuvant postoperative radiation therapy for resectable rectal cancer. Radiat Med 9(4):153-8, 1991. PMID: 1961941.

173.

Wallner K, Chiu-Tsao ST, Roy J, Arterbery VE, Whitmore W, Jain S, Minsky B, Russo P, Fuks Z. An improved method for computerized tomography-planned transperineal 125iodine prostate implants. J Urol 146(1):90-5, 1991. PMID: 1711591.

174.

Minsky BD, Cohen AM, Hajdu SI. Conservative management of anal leiomyosarcoma. Cancer 68(7):1640-3, 1991. PMID: 1893364.

175.

Minsky BD, Kemeny N, Armstrong JG, Reichman B, Botet J. Extrahepatic biliary system cancer: an update of a combined modality approach. Am J Clin Oncol 14(5):433-7, 1991. PMID: 1951179.

176.

Minsky BD, Cohen AM, Fass D, Enker WE, Sigurdson E, Harrison L. Intraoperative brachytherapy alone for incomplete resected recurrent rectal cancer. Radiother Oncol 21(2):115-20, 1991. PMID: 1714083.

177.

Merchant TE, Kasimos JN, de Graaf PW, Minsky BD, Gierke LW, Glonek T. Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy. Int J Colorectal Dis 6(2):121-6, 1991. PMID: 1875121.

178.

Minsky BD, Kemeny N, Cohen AM, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer 67(11):2859-66, 1991. PMID: 2025851.

179.

Minsky BD, Cohen AM, Enker WE, Sigurdson E, Harrison LB. Radiation therapy for unresectable rectal cancer. Int J Radiat Oncol Biol Phys 21(5):1283-9, 1991. PMID: 1938525.

180.

Minsky BD, Cohen AM, Enker WE, Mies C. Sphincter preservation in rectal cancer by local excision and postoperative radiation therapy. Cancer 67(4):908-14, 1991. PMID: 1991263.

181.

Cohen AM, Minsky BD. A phase I trial of preoperative radiation, proctectomy, and endoanal reconstruction. Arch Surg 125(2):247-51, 1990. PMID: 2302064.

182.

Cohen AM, Minsky BD. Aggressive surgical management of locally advanced primary and recurrent rectal cancer. Current status and future directions. Dis Colon Rectum 33(5):432-8, 1990. PMID: 2183979.

183.

Minsky BD. Clinicopathologic impact of colloid in colorectal carcinoma. Dis Colon Rectum 33(8):714-9, 1990. PMID: 2165455.

184.

Minsky BD, Wesson MF, Armstrong JG, Kemeny N, Reichman B, Botet J, Nori D. Combined modality therapy of extrahepatic biliary system cancer. Int J Radiat Oncol Biol Phys 18(5):1157-63, 1990. PMID: 2347722.

185.

Kelsen DP, Minsky B, Smith M, Beitler J, Niedzwiecki D, Chapman D, Bains M, Burt M, Heelan R, Hilaris B. Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. J Clin Oncol 8(8):1352-61, 1990. PMID: 1696309.

186.

Cohen AM, Enker WE, Minsky BD. Proctectomy and coloanal reconstruction for rectal cancer. Dis Colon Rectum 33(1):40-3, 1990. PMID: 2295276.

187.

Kemeny N, Israel K, Niedzwiecki D, Chapman D, Botet J, Minsky B, Vinciguerra V, Rosenbluth R, Bosselli B, Cochran C. Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer. J Clin Oncol 8(2):313-8, 1990. PMID: 2405107.

188.

Minsky BD, Cohen AM, Hajdu SI, Nori D. Sphincter preservation in rectal sarcoma. Dis Colon Rectum 33(4):319-22, 1990. PMID: 2323283.

189.

Minsky BD, Shank B, Nori, D, Linares L, Enker W, Cohen AM. Subtotal resection and brachytherapy in recurrent rectosigmoid and rectal cancer. Endocurie Hypertherm Oncol 6:31-40, 1990.

190.

Armstrong JG, Harrison LB, Dattoli M, Concepcion R, Minsky BD, Fortner J. The use of a prosthetic tissue expander to displace bowel from a brachytherapy implant site. Int J Radiat Oncol Biol Phys 19(6):1521-3, 1990. PMID: 2262376.

191.

Minsky BD, Cohen AM. Adjuvant external beam and intraoperative radiation therapy in rectal cancer. Cancer Invest 7(5):493-507, 1989. PMID: 2695231.

192.

Minsky BD, Mies C, Rich TA, Recht A. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. Int J Radiat Oncol Biol Phys 17(2):311-8, 1989. PMID: 2546907.

193.

Minsky BD, Rich T, Recht A, Harvey W, Mies C. Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer. Cancer 63(7):1421-9, 1989. PMID: 2920368.

194.

Minsky B, Mies C. The clinical significance of vascular invasion in colorectal cancer. Dis Colon Rectum 32(9):794-803, 1989. PMID: 2474414.

195.

Minsky BD, Cohen AM. Minimizing the toxicity of pelvic radiation therapy in rectal cancer. Oncology (Williston Park) 2(8):21-5, 28-9, 1988. PMID: 3275055.

196.

Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potentially curative surgery of colon cancer: patterns of failure and survival. J Clin Oncol 6(1):106-18, 1988. PMID: 2826711.

197.

Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potentially curative surgery of colon cancer: the influence of blood vessel invasion. J Clin Oncol 6(1):119-27, 1988. PMID: 2826712.

198.

Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT. Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival. Cancer 61(7):1408-16, 1988. PMID: 3345493.

199.

Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer 61(7):1417-24, 1988. PMID: 3345494.

200.

Minsky BD, Hilaris B, Fuks Z. The role of radiation therapy in the control of pain from pancreatic carcinoma. J Pain Symptom Manage 3(4):199-205, 1988. PMID: 2461422.

201.

Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Colloid carcinoma of the colon and rectum. Cancer 60(12):3103-12, 1987. PMID: 2824024.

202.

Minsky BD, Siddon RL, Recht A, Nagel JS. Dosimetry of aqueous 32P after soft-tissue infiltration following attempted intravenous administration. Health Phys 52(1):87-9, 1987. PMID: 3804749.

203.

Minsky BD, Mies C, Rich TA. Leiomyosarcoma of the anus treated with sphincter-preserving surgery and radiation therapy. J Surg Oncol 32(2):89-91, 1986. PMID: 3088333.

204.

Chlapowski FJ, Minsky BD, Jacobs JB, Cohen SM. Effect of a collagen substrate on the growth and development of normal and tumorigenic rat urothelial cells. J Urol 130(6):1211-6, 1983. PMID: 6644910.

205.

Minsky BD, Chlapowski FJ. Morphometric analysis of the translocation of luminal membrane between cytoplasm and cell surface of transitional epithelial cells during the expansion-contraction cycles of mammalian urinary bladder. J Cell Biol 77(3):685-97, 1978.

206.

Minsky BD, Braun A. X-ray-mediated cross linking of protein and DNA. Radiat Res 71(3):505-15, 1977. PMID: 897079.

Invited Articles

1.

Minsky BD. Counterpoint: long-course chemoradiation is preferable in the neoadjuvant treatment of rectal cancer. Semin Radiat Oncol 21(3):228-33, 2011. PMID: 21645868.

2.

Benson AB, Guillem JG, Minsky BD. Have the changes in treatment of rectal cancer made a significant difference to our patients? Oncology (Williston Park) 25(14):1323-9, 2011. PMID: 22329182.

3.

Minsky BD. Progress in the treatment of locally advanced clinically resectable rectal cancer. Clin Colorectal Cancer 10(4):227-37, 2011. PMID: 21974841.

4.

Minsky BD. Chemoradiation for rectal cancer: rationale, approaches, and controversies. Surg Oncol Clin N Am 19(4):803-18, 2010. PMID: 20883955.

5.

Minsky BD, Redel C, Valentini V. Combined modality therapy for rectal cancer. Cancer J 16(3):253-61, 2010. PMID: 20526104.

6.

Minsky BD, Guillem JG. Multidisciplinary management of resectable rectal cancer. New developments and controversies. Oncology (Williston Park) 22(12):1430-7, 2008. PMID: 19086601.

7.

Liauw SL, Minsky BD. The use of capecitabine in the combined-modality therapy for rectal cancer. Clin Colorectal Cancer 7(2):99-104, 2008. PMID: 18501068.

8.

Minsky BD. Primary combined-modality therapy for esophageal cancer. Oncology (Williston Park) 20(5), 2006. PMID: 16739747.

9.

Minsky BD. Treatment of unresectable/recurrent rectal cancer with external beam and/or intraoperative radiation techniques. Sem Colon Rectal Surg 16:155-161, 2005.

10.

Eng C, Abbruzzese J, Minsky BD. Chemotherapy and radiation of anal canal cancer: the first approach. Surg Oncol Clin N Am 13(2):309-20, viii, 2004. PMID: 15137959.

11.

Minsky BD. Combined modality therapy of resectable rectal cancer: current approaches. Tech Coloproctol 8(2):67-76, 2004. PMID: 15309641.

12.

Minsky BD. Combined-modality therapy of rectal cancer with irinotecan-based regimens. Oncology (Williston Park) 18(14 Suppl 14):49-55, 2004. PMID: 15685836.

13.

Minsky BD. Combined-modality therapy of rectal cancer with oxaliplatin-based regimens. Clin Colorectal Cancer 4 Suppl 1:S29-36, 2004. PMID: 15212703.

14.

Brenner B, Ilson DH, Minsky BD. Treatment of localized esophageal cancer. Semin Oncol 31(4):554-65, 2004. PMID: 15297946.

15.

Minsky BD. Adjuvant therapy for rectal cancer--the transatlantic view. Colorectal Dis 5(5):416-22, 2003. PMID: 12925072.

16.

Minsky BD. Combined modality therapy for esophageal cancer. Semin Oncol 30(4 Suppl 9):46-55, 2003. PMID: 12908136.

17.

Ilson DH, Minsky B. Irinotecan in esophageal cancer. Oncology (Williston Park) 17(9 Suppl 8):32-6, 2003. PMID: 14569846.

18.

Minsky BD. Oxaliplatin-based combined-modality therapy for rectal cancer. Semin Oncol 30(4 Suppl 15):26-33, 2003. PMID: 14523792.

19.

Minsky BD. The role of radiation therapy in the treatment of esophagus cancer. Esophagus 1:5-15, 2003.

20.

Minsky BD. Adjuvant therapy for rectal cancer. Eur Surg 34:35-39, 2002.

21.

Saltz LB, Minsky B. Adjuvant therapy of cancers of the colon and rectum. Surg Clin North Am 82(5):1035-58, 2002. PMID: 12507208.

22.

Minsky BD. Adjuvant therapy of resectable rectal cancer. Cancer Treat Rev 28(4):181-8, 2002. PMID: 12363458.

23.

Minsky BD. Combined-modality therapy for rectal cancer using irinotecan. Oncology (Williston Park) 16(5 Suppl 5):35-8, 2002. PMID: 12109805.

24.

Ilson DH, Minsky B, Kelsen D. Irinotecan, cisplatin, and radiation in esophageal cancer. Oncology 16:11-16, 2002.

25.

Minsky BD. Postoperative adjuvant therapy for resectable rectal cancer. Sem Colon Rectal Surg 12:194-198, 2002.

26.

Minsky BD. Radiation plus chemotherapy as adjuvant therapy for rectal cancer. Best Pract Res Clin Gastroenterol 16(2):267-82, 2002. PMID: 11969238.

27.

Minsky BD. Toxicity of pelvic radiation therapy. Sem Colon Rectal Surg 12:246-251, 2002.

28.

Minsky BD. Adjuvant therapy of rectal cancer. Osp Ital Chir 6:623-629, 2001.

29.

Wagman RT, Minsky BD. Conservative management of rectal cancer with local excision and adjuvant therapy. Oncology (Williston Park) 15(4):513-9, 2001. PMID: 11346936.

30.

Minsky BD. Present indications for adjuvant therapy in resectable rectal cancer. Ann Ital Chir 72(5):519-26, 2001. PMID: 11975405.

31.

Minsky BD. UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review. Int J Cancer 96(1):1-10, 2001. PMID: 11241325.

32.

Minsky BD. Preoperative adjuvant therapy for rectal cancer. Oncologia Clinica 5:400-404, 2000.

33.

Minsky BD. Adjuvant postoperative combined-modality therapy for rectal cancer. Oncology (Williston Park) 13(7 Suppl 3):132-5, 1999. PMID: 10442383.

34.

Minsky BD. Adjuvant therapy of rectal cancer. Semin Oncol 26(5):540-4, 1999. PMID: 10528902.

35.

Minsky BD. Carcinoma of the esophagus. Part 1: Primary therapy. Oncology (Williston Park) 13(9):1225-32, 1235-6, 1999. PMID: 10509320.

36.

Minsky BD. Carcinoma of the esophagus. Part 2: Adjuvant therapy. Oncology (Williston Park) 13(10):1415-27, 1999. PMID: 10549567.

37.

Minsky BD. Primary treatment of rectal cancer: present and future. Crit Rev Oncol Hematol 32(1):19-30, 1999. PMID: 10586352.

38.

Minsky BD. Role of adjuvant therapy in adenocarcinoma of the rectum. Semin Surg Oncol 17(3):189-98, 1999. PMID: 10504667.

39.

Minsky BD. Sphincter preservation in rectal cancer. Int J Clin Oncol 4:2-8, 1999.

40.

Minsky BD. Adjuvant combined modality therapy for rectal cancer. Cancer Treat Res 98:153-71, 1998. PMID: 10326668.

41.

Minsky BD. Adjuvant therapy for rectal cancer: results and controversies. Oncology (Williston Park) 12(8):1129-39, 1998. PMID: 11236307.

42.

Minsky BD. Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis. Semin Radiat Oncol 8(1):30-5, 1998. PMID: 9516581.

43.

Cohen AM, Kelsen D, Saltz L, Minsky BD, Nelson H, Farouk R, Gunderson LL, Michelassi F, Arenas RB, Schilsky RL, Willet CG. Adjuvant therapy for colorectal cancer. Curr Probl Surg 34(8):601-76, 1997. PMID: 9251585.

44.

Minsky BD. Current and future directions in adjuvant combined-modality therapy of rectal cancer. Oncology (Williston Park) 11(9 Suppl 10):61-8, 1997. PMID: 9348572.

45.

Minsky BD. Results of local excision followed by postoperative radiation therapy for rectal cancer. Radiat Oncol Investig 5(5):246-51, 1997. PMID: 9372547.

46.

Minsky BD. The role of adjuvant radiation therapy in the treatment of colorectal cancer. Hematol Oncol Clin North Am 11(4):679-97, 1997. PMID: 9257151.

47.

Minsky BD. The role of radiation therapy in rectal cancer. Semin Oncol 24(5 Suppl 18):S18-25-S18-29, 1997. PMID: 9420018.

48.

Minsky BD. Multidisciplinary management of resectable rectal cancer. Oncology (Williston Park) 10(11):1701-8, 1713-4, 1996. PMID: 8953589.

49.

Minsky BD. Palliative radiation therapy and combined modality therapy for esophagus cancer. Dis Esoph 9:86-89, 1996.

50.

Minsky BD. Radiation therapy alone or combined with chemotherapy in the treatment of esophageal cancer. Recent Results Cancer Res 142:217-35, 1996. PMID: 8893344.

51.

Minsky BD. The role of radiation therapy in gastric cancer. Semin Oncol 23(3):390-6, 1996. PMID: 8658223.

52.

Minsky BD. Adjuvant radiation therapy for colon cancer. Cancer Treat Rev 21(5):407-14, 1995. PMID: 8556716.

53.

Minsky BD. Conservative treatment of rectal cancer with local excision and postoperative radiation therapy. Eur J Cancer 31A(7-8):1343-6, 1995. PMID: 7577048.

54.

Minsky BD. Management of locally advanced/unresectable rectal cancer. Radiat Oncol Invest 3:97-107, 1995.

55.

Minsky BD. Preoperative combined modality treatment for rectal cancer. Oncology (Williston Park) 8(5):53-8, 1994. PMID: 8025007.

56.

Minsky BD. The Adjuvant Treatment of Esophageal Cancer. Semin Radiat Oncol 4(3):165-169, 1994. PMID: 10717104.

57.

Minsky BD. Pelvic Radiation Therapy in Rectal Cancer: Technical Considerations. Semin Radiat Oncol 3(1):42-47, 1993. PMID: 10717051.

58.

Minsky BD. Radiation therapy as a sphincter-preserving technique in distal invasive rectal cancer. Cancer Treat Rev 17(4):379-88, 1990. PMID: 2093423.

59.

Minsky BD, Cohen AM. Conservative management of invasive rectal cancer: alternative to abdominoperineal resection. Oncology (Williston Park) 3(5):137-42, 1989. PMID: 2491441.

60.

Armstrong JG, Minsky BD. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 16(4):247-55, 1989. PMID: 2561593.

61.

Minsky BD, Leibel SA. The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole. Cancer Treat Rev 16(4):213-9, 1989. PMID: 2700316.

mp327's picture
mp327
Posts: 2820
Joined: Jan 2010

I was in that exact situation near the end of my treatment.  I had only 3 more to go, but was ready to bail out, as I didn't think I could take anymore pain.  However, I learned that the last few treatments, perhaps 5, are the "coning down" phase, which means the treatment area is targeted only to the tumor.  This is pretty standard procedure and it's likely that your protocol is the same.  The last few are called "boosts" and they CAN make a difference.  I know it's very rough for you right now, believe me, I do.  However, to make the treatment as effective as possible, you must get those last 4 treatments.  You CAN do this!  Take plenty of pain medication and if it's not doing the job, ask for more or something different.  Some people, including me, found relief soaking in the tub a few times a day.  Others say that ice applied to the burned area helps.  You'll just have to see what works for you.  Domeboro has also been recommended.  Do a Google and check that out.  Hang in there, you'll get through this, then the healing can begin! 

eihtak
Posts: 809
Joined: Oct 2011

You're so close. We've been there and know how awful this point is, but you can finish. In the end I was on a regular schedule of oxycontin twice a day with oxycodone in between. I didn't need it for too long after but sure helped at the end. Don't be afraid to ask your doc for something to help. I believe those last few treatments are important in most cases. I will have you in my thoughts and prayers as you finish up and move forward in healing!!

LaCh
Posts: 509
Joined: Dec 2012

The finish line is in sight. Take narcotic painkillers, do whatever you need to do. I'm no supporter of this treatment and had, and still have, grave doubts about it and I was in the same boat, about to bail a few days before the end. It seems --statistically--that the full dosage of grays (the measure of radiation you receive) does make a difference in the outcome. To come this far and quit now will undermine the treatments you've already endured. So you'll start to heal four days sooner.  That's good, but you don't want to be asking yourself if you'd have had a different outcome a year or so down the road if you don't get a cure or do have a remission.  I'm not saying that you will. No one can know that. But you just don't want to open the door for regret.  Stumble to the finish line, fall across the finish line, do whatever you need to do but just get it done.  I know that it's not a warm and fuzzy response but you can find those elsewhere.  By the end, I had third degree burns externally and a tear internally and wanted only one thing. Sudden death which meant immediate relief. But you just put one foot in front of the other and do it.  Then you're done and the external healing is relatively rapid and seems to be so for the vast majority. People do this. You can do it too. 

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2014 © Cancer Survivors Network